B.r. Pharmaceuticals Limited in Leeds, LS16 6QE

Description

Data updated on: 01-11-2023

03164815 - registration number used by B.r. Pharmaceuticals Limited. It was registered as a Private Limited Company on Tuesday 27th February 1996. It has existed on the market for twenty eight years. This firm can be found at Clayton Wood Close West Park Ring Road in Leeds. It's postal code assigned to this location is LS16 6QE. The firm's SIC and NACE codes are 46460 meaning Wholesale of pharmaceutical goods. 2022-12-31 is the last time company accounts were filed.

The details detailing this particular firm's members implies that there are three directors: Taisir A., Ziad A. and Omar A. who joined the team on Tuesday 20th March 2018, Wednesday 21st August 2013.

Omar A. is the individual who has control over this firm, owns 1/2 or less of company shares and has 1/2 or less of voting rights.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31
Currency	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Net Worth	860 638	752 204	689 312	837 689

Balance Sheet
Cash Bank On Hand					22 535	10 552	14 275	338 206	587 003	1 203 443	1 378 728	1 327 955
Current Assets	1 034 336	1 085 652	1 110 031	958 932	478 656	587 823	659 031	928 144	1 412 731	2 618 671	2 806 898	3 410 578
Debtors	538 598	606 320	628 648	401 588	289 911	347 082	387 647	425 090	571 488	1 055 867	923 245	1 579 972
Net Assets Liabilities					794 200	854 320	988 368	1 128 642	1 481 246	2 110 782	2 892 422	3 482 617
Other Debtors					140 080	76 378	76 817	38 602	78 996	192 375	175 895
Property Plant Equipment					806 236	798 140	765 340	749 994	732 631	752 083	903 389	896 843
Total Inventories					166 210	230 189	257 109	164 848	254 240	359 361	504 925	502 651
Cash Bank In Hand	4 426	48 291	727	664
Intangible Fixed Assets	35 241	31 088	28 565	31 823
Net Assets Liabilities Including Pension Asset Liability	860 638	752 204	689 312	837 689
Stocks Inventory	491 312	431 041	480 656	556 680
Tangible Fixed Assets	860 516	888 882	839 510	1 232 826

Capital & Reserves
Called Up Share Capital	70 002	70 002	70 002	70 002
Profit Loss Account Reserve	770 636	662 202	599 310	291 459
Shareholder Funds	860 638	752 204	689 312	837 689

Other Financial Data
Instalment Debts Falling Due After5 Years	62 555	0
Secured Debts	432 485	386 047	336 925	245 163
Tangible Fixed Assets Depreciation Other Adjustments				-767 544
Total Fixed Assets Additions		120 292	46 840	11 407
Total Fixed Assets Cost Or Valuation	1 795 971	1 900 629	1 947 466	1 594 221
Total Fixed Assets Depreciation	900 211	980 656	1 079 391	329 572
Total Fixed Assets Depreciation Charge In Period		96 080	98 735	54 783
Total Fixed Assets Depreciation Disposals		-15 635		-37 058
Total Fixed Assets Depreciation Other Adjustments				-767 544
Total Fixed Assets Disposals		-15 634	-3	-53 336
Total Fixed Assets Revaluation				-311 316
Version Production Software												1
Accumulated Amortisation Impairment Intangible Assets					30 018	35 225	40 016	18 286	14 229	17 498	20 760	23 876
Accumulated Depreciation Impairment Property Plant Equipment					99 418	129 714	162 858	168 854	201 216	235 681	284 249	345 499
Additions Other Than Through Business Combinations Intangible Assets						3 495		2 275	5 515	2 190		2 029
Additions Other Than Through Business Combinations Property Plant Equipment						22 200	344	16 314	14 999	53 917	199 874	54 704
Administrative Expenses					439 474	618 903
Amortisation Expense Intangible Assets					6 509	5 207
Amortisation Rate Used For Intangible Assets						10	10	10	10	10	10
Average Number Employees During Period						13	12	10	12	15	15	15
Bank Borrowings Overdrafts					69 537	116 195	51 519
Cancellation Subscribed Capital Decrease In Equity						-2
Comprehensive Income Expense					4 261	60 120
Corporation Tax Payable					23 003	2 607	1 919	32 118	86 864	141 103	152 937
Cost Sales					1 204 726	1 277 024
Creditors					519 111	555 668	455 778	565 029	481 955	1 076 732	567 880	574 490
Deferred Tax Liabilities					-7 441	-1 226					63 483
Depreciation Expense Property Plant Equipment					45 201	30 296
Depreciation Rate Used For Property Plant Equipment						10	10	10	10	25	10
Depreciation Transfer Revaluation Surplus Before Tax Increase Decrease In Equity					-96 212
Disposals Decrease In Amortisation Impairment Intangible Assets								26 265	7 266
Disposals Decrease In Depreciation Impairment Property Plant Equipment								24 756
Disposals Intangible Assets								28 247	7 266
Disposals Property Plant Equipment								25 664
Distribution Costs					53 332	48 234
Dividends Paid					47 750
Dividends Paid On Shares					47 750
Finance Lease Payments Owing Minimum Gross					8 834	5 301	1 767
Fixed Assets	895 760	919 973	868 075	1 264 649	832 514	822 706	785 115	765 527	750 470	768 843	916 887	909 254
Gross Profit Loss					613 655	728 342
Income Expense Recognised Directly In Equity					-47 750	-2
Increase From Amortisation Charge For Year Intangible Assets						5 207	4 791	4 535	3 209	3 269	3 262	3 116
Increase From Depreciation Charge For Year Property Plant Equipment						30 296	33 144	30 752	32 362	34 465	48 568	61 250
Intangible Assets					26 278	24 566	19 775	15 533	17 839	16 760	13 498	12 411
Intangible Assets Gross Cost					56 296	59 791	59 791	33 819	32 068	34 258	34 258	36 287
Interest Expense On Obligations Under Finance Leases Hire Purchase Contracts					3 480	462
Interest Payable Similar Charges Finance Costs					10 920	6 012
Net Current Assets Liabilities	411 260	244 681	181 558	-181 797	-40 455	32 155	203 253	363 115	930 776	1 541 939	2 239 018	2 836 088
Net Deferred Tax Liability Asset					-17 556	-7 441	-1 226
Operating Profit Loss					127 665	74 241
Other Creditors					169 185	193 979	65 774	172 755	18 285	87 749	25 509
Other Interest Receivable Similar Income Finance Income					3	20
Other Operating Income Format1					6 816	13 036
Other Taxation Social Security Payable					10 683	24 525	27 867	19 910	57 018	54 944	55 298
Profit Loss					100 473	60 120
Profit Loss Before Tax					116 748	68 249
Profit Loss On Ordinary Activities Before Tax					116 748	68 249
Property Plant Equipment Gross Cost					905 654	927 854	928 198	918 848	933 847	987 764	1 187 638	1 242 342
Provisions For Liabilities Balance Sheet Subtotal											63 483	62 725
Raw Materials					166 210	230 189
Redemption Shares Decrease In Equity						2
Taxation Including Deferred Taxation Balance Sheet Subtotal					-7 441	-1 226					63 483
Tax Tax Credit On Profit Or Loss On Ordinary Activities					16 275	8 129
Total Assets Less Current Liabilities	1 307 020	1 164 654	1 049 633	1 082 852	792 059	854 861	988 368	1 128 642	1 681 246	2 310 782	3 155 905	3 745 342
Trade Creditors Trade Payables					246 703	218 362	308 699	340 246	319 788	792 936	334 136	284 257
Trade Debtors Trade Receivables					149 831	270 704	310 830	386 488	492 492	863 492	747 350	614 537
Turnover Revenue					1 818 381	2 005 366
Advances Credits Directors				42 717	33
Advances Credits Made In Period Directors					42 750
Advances Credits Repaid In Period Directors						33
Creditors Due After One Year Total Noncurrent Liabilities	432 485	386 047	336 925	245 163
Creditors Due Within One Year Total Current Liabilities	623 076	840 971	928 473	1 140 729
Intangible Fixed Assets Additions		4 151	6 189	11 407
Intangible Fixed Assets Aggregate Amortisation Impairment	57 456	65 760	74 472	82 621
Intangible Fixed Assets Amortisation Charged In Period		8 304	8 712	8 149
Intangible Fixed Assets Cost Or Valuation	92 697	96 848	103 037	114 444
Provisions For Liabilities Charges	13 897	26 403	23 396	0
Revaluation Reserve			0	456 228
Share Premium Account	20 000	20 000	20 000	20 000
Tangible Fixed Assets Additions		116 141	40 651
Tangible Fixed Assets Cost Or Valuation	1 703 271	1 803 778	1 844 429	1 479 777
Tangible Fixed Assets Depreciation	842 755	914 896	1 004 919	246 951
Tangible Fixed Assets Depreciation Charge For Period		87 776	90 023	46 634
Tangible Fixed Assets Depreciation Disposals		-15 635		-37 058
Tangible Fixed Assets Disposals		-15 634		-53 336
Tangible Fixed Assets Increase Decrease From Revaluations				-311 316
Total Fixed Asset Investments Cost Or Valuation	3	3	0
Total Fixed Asset Investments Disposals			-3
Total Investments Fixed Assets	3	3	0

Company staff

Taisir A.

Role: Director

Appointed: 20 March 2018

Latest update: 29 March 2024

Ziad A.

Role: Director

Appointed: 20 March 2018

Latest update: 29 March 2024

Omar A.

Role: Director

Appointed: 21 August 2013

Latest update: 29 March 2024

Gregory D.

Role: Director

Appointed: 21 May 2007

Resigned: 30 August 2013

Latest update: 29 March 2024

Geoffrey P.

Role: Director

Appointed: 01 November 2004

Resigned: 08 August 2005

Latest update: 29 March 2024

Emma T.

Role: Director

Appointed: 05 April 2004

Resigned: 23 December 2010

Latest update: 29 March 2024

Christopher H.

Role: Director

Appointed: 01 May 2003

Resigned: 14 June 2004

Latest update: 29 March 2024

Emma T.

Role: Secretary

Appointed: 27 January 2003

Resigned: 23 December 2010

Latest update: 29 March 2024

Christopher K.

Role: Director

Appointed: 07 June 1999

Resigned: 31 December 2000

Latest update: 29 March 2024

Patrick R.

Role: Director

Appointed: 01 April 1996

Resigned: 21 August 2013

Latest update: 29 March 2024

Phillip B.

Role: Director

Appointed: 29 March 1996

Resigned: 20 March 2018

Latest update: 29 March 2024

Phillip B.

Role: Secretary

Appointed: 29 March 1996

Resigned: 27 January 2003

Latest update: 29 March 2024

Willoughby Corporate Secretarial Limited

Role: Corporate Secretary

Appointed: 27 February 1996

Resigned: 01 April 1996

Address: 20 Low Pavement, Nottingham, Nottinghamshire, NG1 7EA

Latest update: 29 March 2024

Willoughby Corporate Registrars Limited

Role: Corporate Director

Appointed: 27 February 1996

Resigned: 29 March 1996

Address: Nottingham, NG1 6HH

Latest update: 29 March 2024

People with significant control

Omar A.

Notified on 6 April 2016

Nature of control:

1/2 or less of voting rights

1/2 or less of shares

Taisir A.

Notified on 20 March 2018

Ceased on 26 April 2018

Nature of control:

substantial control or influence

Ziad A.

Notified on 20 March 2018

Ceased on 26 April 2018

Nature of control:

substantial control or influence

Phillip B.

Notified on 6 April 2016

Ceased on 20 March 2018

Nature of control:

1/2 or less of voting rights

1/2 or less of shares

Accounts Documents

Account next due date	30 September 2024
Account last made up date	31 December 2022
Confirmation statement next due date	23 February 2024
Confirmation statement last made up date	09 February 2023

Annual Accounts
Start Date For Period Covered By Report	2016-01-01
End Date For Period Covered By Report	31 December 2016
Annual Accounts
Start Date For Period Covered By Report	2017-01-01
End Date For Period Covered By Report	31 December 2017
Annual Accounts
Start Date For Period Covered By Report	2018-01-01
End Date For Period Covered By Report	31 December 2018
Annual Accounts
Start Date For Period Covered By Report	2019-01-01
End Date For Period Covered By Report	31 December 2019
Annual Accounts
Start Date For Period Covered By Report	2020-01-01
End Date For Period Covered By Report	31 December 2020
Annual Accounts
Start Date For Period Covered By Report	2021-01-01
End Date For Period Covered By Report	31 December 2021
Annual Accounts
Start Date For Period Covered By Report	2022-01-01
End Date For Period Covered By Report	2022-12-31

B.r. Pharmaceuticals Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Taisir A.

Ziad A.

Omar A.

Gregory D.

Geoffrey P.

Emma T.

Christopher H.

Emma T.

Christopher K.

Patrick R.

Phillip B.

Phillip B.

Willoughby Corporate Secretarial Limited

Willoughby Corporate Registrars Limited

People with significant control

Omar A.

Taisir A.

Ziad A.

Phillip B.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies